Submit the form below to share this page with a friend or colleague. Genentech will not contact the individuals you share content with.
All fields are required.
The resources on this page describe selected disease states and recent advances in our understanding of disease processes.
Lung cancer is the second most commonly occurring malignancy in men and women.5 As our scientific understanding of the heterogeneity of lung cancer grows, the emergence of genetic markers and signaling pathways provides an opportunity to customize therapy for clinically distinct diseases.
Click here to contact a Genentech Account Manager about additional resources and tools.